Jacobs & Co’s Merck MRK Stock Holding History

Jacobs & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4M	Sell	103,952 -2,897	-3%	-$339K	1.15%	27
2026 Q1	$12.9M	Sell	106,849 -2,220	-2%	-$256K	1.27%	29
2025 Q4	$11.5M	Sell	109,069 -229	-0.2%	-$21.5K	1.08%	37
2025 Q3	$9.17M	Sell	109,298 -1,709	-2%	-$141K	0.88%	44
2025 Q2	$8.79M	Sell	111,007 -3,223	-3%	-$256K	0.87%	49
2025 Q1	$10.3M	Buy	114,230 +589	+0.5%	+$55K	1.09%	34
2024 Q4	$11.3M	Buy	113,641 +4,751	+4%	+$490K	1.15%	33
2024 Q3	$12.4M	Buy	108,890 +6,407	+6%	+$761K	1.24%	30
2024 Q2	$12.7M	Sell	102,483 -707	-0.7%	-$91.1K	1.33%	25
2024 Q1	$13.6M	Sell	103,190 -3,133	-3%	-$386K	1.44%	22
2023 Q4	$11.6M	Buy	106,323 +5,071	+5%	+$526K	1.31%	31
2023 Q3	$10.4M	Buy	101,252 +1,298	+1%	+$140K	1.3%	32
2023 Q2	$11.5M	Sell	99,954 -6,026	-6%	-$684K	1.37%	27
2023 Q1	$11.3M	Sell	105,980 -7,928	-7%	-$856K	1.39%	24
2022 Q4	$12.6M	Sell	113,908 -14,002	-11%	-$1.43M	1.64%	15
2022 Q3	$11M	Sell	127,910 -1,498	-1%	-$134K	1.58%	16
2022 Q2	$11.8M	Sell	129,408 -10,681	-8%	-$947K	1.58%	19
2022 Q1	$11.5M	Sell	140,089 -1,911	-1%	-$151K	1.27%	32
2021 Q4	$10.9M	Buy	142,000 +4,424	+3%	+$352K	1.13%	36
2021 Q3	$10.3M	Buy	137,576 +8,702	+7%	+$662K	1.19%	33
2021 Q2	$10M	Buy	128,874 +10,181	+9%	+$757K	1.16%	35
2021 Q1	$8.73M	Buy	118,693 +10,693	+10%	+$789K	1.07%	43
2020 Q4	$8.43M	Buy	108,000 +10,814	+11%	+$827K	1.09%	38
2020 Q3	$7.69M	Buy	97,186 +5,575	+6%	+$437K	1.12%	37
2020 Q2	$6.76M	Buy	91,611 +9,520	+12%	+$717K	1.1%	34
2020 Q1	$6.03M	Buy	82,091 +987	+1%	+$77.6K	1.16%	34
2019 Q4	$7.04M	Buy	81,104 +6,946	+9%	+$571K	1.07%	36
2019 Q3	$5.96M	Buy	74,158 +687	+0.9%	+$55.1K	0.97%	41
2019 Q2	$5.88M	Buy	73,471 +26,943	+58%	+$2.06M	0.95%	40
2019 Q1	$3.69M	Sell	46,528 -357	-0.8%	-$26.7K	0.63%	61
2018 Q4	$3.42M	Sell	46,885 -1,436	-3%	-$101K	0.67%	56
2018 Q3	$3.27M	Sell	48,321 -2,051	-4%	-$131K	0.55%	65
2018 Q2	$2.92M	Sell	50,372 -2,988	-6%	-$169K	0.53%	68
2018 Q1	$2.77M	Buy	53,360 +198	+0.4%	+$10.7K	0.51%	70
2017 Q4	$2.85M	Sell	53,162 -550	-1%	-$30.5K	0.52%	72
2017 Q3	$3.28M	Buy	53,712 +1,624	+3%	+$98.5K	0.62%	67
2017 Q2	$3.19M	Sell	52,088 -215	-0.4%	-$13.1K	0.63%	67
2017 Q1	$3.17M	Buy	52,303 +872	+2%	+$52.9K	0.65%	66
2016 Q4	$2.89M	Buy	51,431 +3,375	+7%	+$198K	0.63%	65
2016 Q3	$2.86M	Sell	48,056 -262	-0.5%	-$15.3K	0.64%	63
2016 Q2	$2.66M	Sell	48,318 -603	-1%	-$32.1K	0.62%	64
2016 Q1	$2.47M	Buy	48,921 +14	+0%	+$686	0.59%	63
2015 Q4	$2.42M	Sell	48,907 -877	-2%	-$44.2K	0.63%	62
2015 Q3	$2.35M	Buy	49,784 +461	+0.9%	+$24.5K	0.62%	61
2015 Q2	$2.68M	Buy	49,323 +1,147	+2%	+$64.3K	0.67%	63
2015 Q1	$2.64M	Sell	48,176 -26	-0.1%	-$1.47K	0.67%	64
2014 Q4	$2.61M	Buy	48,202 +4,596	+11%	+$256K	0.69%	60
2014 Q3	$2.47M	Sell	43,606 -105	-0.2%	-$5.9K	0.7%	60
2014 Q2	$2.41M	Buy	43,711 +65	+0.1%	+$3.55K	0.7%	60
2014 Q1	$2.36M	Buy	43,646 +1,551	+4%	+$80.3K	0.73%	55
2013 Q4	$2.01M	Buy	42,095 +210	+0.5%	+$9.6K	0.64%	64
2013 Q3	$1.9M	Sell	41,885 -2,096	-5%	-$95.7K	0.66%	65
2013 Q2	$1.95M	Buy	+43,981	New	+$1.96M	0.71%	56

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Jacobs & Co's MRK Position: Q2 2026 in Review

Jacobs & Co reduced its Merck (MRK) stake by 2.7% in Q2 2026, selling an estimated $339K and leaving 103,952 shares worth $13.4M. The position accounts for 1.15% of the portfolio, ranked #27.

Jacobs & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.6M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Jacobs & Co held 103,952 shares of Merck worth $13.4M as of Q2 2026.
Jacobs & Co sold 2,897 Merck shares in Q2 2026, an estimated $339K.
Merck made up 1.15% of Jacobs & Co's portfolio in Q2 2026, its #27 holding.
Jacobs & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Jacobs & Co's Merck position peaked at $13.6M in Q1 2024.
1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.